Norway· NO-ID_CAE1DA86-FF26-4CB7-B466-CD25F2D5A0AA

Primovist

A gadoxetsäure product containing gadoxetic acid + disodium, registered in Norway by Bayer AB - Solna. The same ATC class is registered in 12 of our 19 countries.

ATC V08CA10

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedPrimovistATCV08CA10REGISTER NO.NO-ID_CAE1DA86-FF26-4…PACKS LISTED5CHECKEDOctober 2, 2026

Where it is registered

Gadoxetsäure is registered in 12 of 19 countries.

Countries holding a registration under ATC V08CA10 (gadoxetsäure), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 7 of them publish a price we can compare per daily dose

Gadoxetsäure · ATC V08CA10

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Gadoxetic Acid + Disodium
Manufacturer
Bayer AB - Solna
Country
Norway (NO)
ATC code
V08CA10
ATC class
Gadoxetsäure
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
October 2, 2026

Packs & prices · 5

2 priced
  • no_varenummer
    018605
    5 x 10
    NOK 13047.5
  • no_merkevare_id
    ID_CAE1DA86-FF26-4CB7-B466-CD25F2D5A0AA
  • no_varenummer
    172665
    5 x 10
    NOK 13047.5
  • gtin
    4057601001444
  • gtin
    7346260186058

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

34 interactions on record for gadoxetsäure.

Graded by severity as the source publishes them — 34 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Gadoxetsäure · interactions on record

34 records

  • 34 moderate

Most severe, free to view

  • PindololC07AA03moderate
  • PropranololC07AA05moderate
  • TimololC07AA06moderate
  • SotalolC07AA07moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a67125cc-a84e-470a-887f-b678b2308056
GET /v1/drugs/a67125cc-a84e-470a-887f-b678b2308056?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Injeksjonsvæske, oppløsning i ferdigfylt sprøyte",
  "source": "fest",
  "status": "A",
  "atc_name": "Gadoksetsyre",
  "merkevare_id": "ID_CAE1DA86-FF26-4CB7-B466-CD25F2D5A0AA",
  "name_form_strength": "Primovist inj, oppl 0,25 mmol/ml",
  "prescription_group": "C"
}

See everything about gadoxetsäure.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.